InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: None

Friday, 02/24/2017 10:44:31 AM

Friday, February 24, 2017 10:44:31 AM

Post# of 21531
Some DD I've been effortiing.

Alcon has a patent for oral administration of Bryostatin.



US patent 9,446,020






"For oral administration, fine powders or granules containing diluting, dispersing and/or surface-active agents may be presented in a draught, in water or a syrup, in capsules or sachets in the dry state, in a non-aqueous suspension wherein suspending agents may be included, or in a suspension in water or a syrup. Where desirable or necessary, flavouring, preserving, suspending, thickening or emulsifying agents can be included"


http://patents.com/us-9446020.html




Also I believe their licensing deal for synthetic Bryostatin ( if I heard correctly) is exclusive for " neurological" indications. That would virtually eliminate competition who would have to pay $14 million an ounce..

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News